ERBB2 and breast neoplasm: It is important to note that in contrast to the elevated levels of PMCA2 reported in HER2-positive and basal-type tumors12,13, PMCA2 expression remains low in luminal breast tumor subtypes according to data from the CPTAC-GWAS databases (Supplementary Fig. 1a).